The Patent Finder

GBS Global Biopharma, Inc.

Also on record
Records under this name other than the patents GBS Global Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to GBS Global Biopharma, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,980,592Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases
now held by GB Sciences, Inc.
In force
 · High confidence
In forceHigh confidence
US 10,653,640Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases
now held by GB Sciences, Inc.
In force
 · High confidence
In forceHigh confidence
16/686,069Therapeutic Nanoparticles Encapsulating Terpenoids And/Or Cannabinoids
Abandoned
Abandoned Jun 24, 2026
AbandonedAbandoned Jun 24, 2026
16/914,205Treatment of Pain Using Allosteric Modulator of TRPV1
Abandoned
Abandoned May 13, 2024
AbandonedAbandoned May 13, 2024
17/065,400Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders
Abandoned
Abandoned Jul 25, 2024
AbandonedAbandoned Jul 25, 2024
17/406,035Cannabinoid-Containing Complex Mixtures for the Treatment of Cytokine Release Syndrome While Preserving Key Anti-Viral Immune Reactions
Abandoned
Abandoned Sep 18, 2026
AbandonedAbandoned Sep 18, 2026
17/501,498Method and Systems for Phytomedicine Analytics for Research Optimization at Scale
Abandoned
Abandoned Sep 3, 2026
AbandonedAbandoned Sep 3, 2026
17/576,485TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes
Abandoned
Abandoned Nov 27, 2024
AbandonedAbandoned Nov 27, 2024
17/955,425Cannabinoid-Containing Formulations for Parkinsonian Movement Disorders
now held by GB Sciences, Inc.
Abandoned
Abandoned Jun 20, 2024
AbandonedAbandoned Jun 20, 2024
18/601,427Cannabinoid-Containing Complex Mixtures for the Treatment of Cytokine Release Syndrome While Preserving Key Anti-Viral Immune Reactions
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 15 records shown.
Pro members see all 15.
Pro members: see all 15 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited